USE OF LEVONORGESTREL INTRAUTERINE-DEVICE FOR PREVENTION OF ENDOMETRIAL CHANGES INDUCED BY TAMOXIFEN

Authors
VANLIEDEKERKE D GEVERS R DESUTTER P BOURGAIN C AMY JJ
Citation
D. Vanliedekerke et al., USE OF LEVONORGESTREL INTRAUTERINE-DEVICE FOR PREVENTION OF ENDOMETRIAL CHANGES INDUCED BY TAMOXIFEN, European journal of cancer, 34, 1998, pp. 55-56
Citations number
10
Categorie Soggetti
Oncology
Journal title
European journal of cancer → ACNP
ISSN journal
09598049
Volume
34
Year of publication
1998
Supplement
4
Pages
55 - 56
Database
ISI
SICI code
0959-8049(1998)34:<55:UOLIFP>2.0.ZU;2-5
Abstract
The levonorgestrel intrauterine device (LNG-IUD) is a systemic hormona l contraceptive that releases LNG at a steady rate of 20 mu g/24 h in the uterine cavity. The exposed endometrium harbours a concentration o f LNG which is several times higher than that found following oral adm inistration of that progestogen [1]. Small amounts of the compound esc ape into the general circulation. (C) 1998 Elsevier Science Ltd. All r ights reserved.